Allurion Technologies' Elipse Gastric Balloon receives CE Mark: 6 key notes

Allurion Technologies' Elipse Gastric Balloon has received a CE Mark allowing sale of the product in the European Union, according to a Med Device Online report.

Here are six key notes:

1. Elipse is the world's first procedureless gastric balloon for weight loss.

2. It is made of thin, flexible polymer film and is delivered in a swallowable capsule.

3. This is the company's first regulatory approval.

4. Elipse will initially be available in France, Italy and the United Kingdom.

5. Elipse is not yet approved by the FDA.

6. Allurion Technologies is focused on developing less invasive treatments for overweight and obese individuals.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast